Eledon Pharmaceuticals, Inc. (ELDN) vs Protalix BioTherapeutics, Inc. (PLX)
Eledon Pharmaceuticals, Inc. and Protalix BioTherapeutics, Inc. are both Biotechnology companies. Eledon Pharmaceuticals, Inc. and Protalix BioTherapeutics, Inc. are of similar size ($228.3M and $221.6M). Eledon Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Protalix BioTherapeutics, Inc. trades at 11.3×. Protalix BioTherapeutics, Inc. has the higher net margin (23.5% vs 0.00%) and the higher return on invested capital (48.5% vs 0.00%). Across the 13 metrics below, Protalix BioTherapeutics, Inc. leads on 10 and Eledon Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | ELDN | PLX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 69.20% | 65.16% |
| Operating margin | 0.00% | 28.89% | 0.00% |
| Net margin | 0.00% | 23.50% | 0.00% |
| Free cash flow margin | 0.00% | 9.51% | 0.00% |
| Return on equity | (236.51%) | 31.23% | (57.72%) |
| Return on assets | (72.74%) | 20.07% | (49.22%) |
| Return on invested capital | 0.00% | 48.48% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack